Back to search

Article

Identification and validation of M2 macrophage-related differential genes in DLBCL

2024-03-18

Abstract excerpt

<title>Abstract</title> <p>DLBCL is the most prevalent non-Hodgkin lymphoma, with 30-40% of patients are refractory or relapse after conventional immunotherapy. Growing evidence indicate that alterations in tumor microenvironment (TME) play a pivotal role in DLBCL progression, including polarization of macrophages to M2 phenotype, fostering tumor immunosuppressive status. Therefore, exploring molecular TME biomar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65e5a55e-5a1a-5d81-b7d3-3b354c229f2f
DOI
10.21203/rs.3.rs-3997435/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification and validation of M2 macrophage-related differential genes in DLBCLDOI 10.21203/rs.3.rs-3997435/v1
Identification of M2 macrophage-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approachesSemantic proximity
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironmentSemantic proximity
A predictive model based on immune related genes for DLBCLSemantic proximity
Integrated transcriptome and single-cell sequencing reveals M2-like tumor-associated macrophages-related prognostic signatures in breast cancerSemantic proximity
Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinomaSemantic proximity
Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapySemantic proximity
Immunogenic Cell Death-related Signature Evaluates the Tumor Microenvironment and Predicts the Prognosis in Diffuse Large B-Cell LymphomaSemantic proximity
Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor diffuse large B-cell lymphomaSemantic proximity
Comprehensive multi-omics analysis identifies an immune related predicting model in early stage breast cancerSemantic proximity
Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO AlgorithmSemantic proximity
Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell LymphomaSemantic proximity
Landscape of Immune Cell Infiltration and Inflammatory Response-related Gene Signature in Breast Cancer: an Experimental Validation StudySemantic proximity
Select a neighboring publication to make it the new centre.